Mediclinic International PLC

Mediclinic International PLC

Health CareHealth Care Providers
  • Price (GBX)477.40
  • Today's Change35.20 / 7.96%
  • Shares traded3.90m
  • 1 Year change+60.09%
  • Beta0.8180
Data delayed at least 20 minutes, as of Jul 07 2022 12:17 BST.
More ▼
Take Action
Take Action
Add this security to watchlist, portfolio, or create an alert to track market movement

Key statistics

Mediclinic International PLC (MDC:LSE) set a new 52-week high during today's trading session when it reached 490.40. Over this period, the share price is up 61.17%.
52-week range
271.40Aug 10 2021490.40Jul 07 2022
Markit short selling activity
Previous close442.20
Average volume2.57m
Shares outstanding737.24m
Free float402.77m
P/E (TTM)21.57
Market cap3.26bn GBP
EPS (TTM)0.205
Annual div (ADY)--
Annual div yield (ADY)0.67%
Div ex-dateDec 05 2019
Div pay-dateDec 17 2019
Next div ex-dateAug 04 2022
Next div pay-dateAug 26 2022
Data delayed at least 20 minutes, as of Jul 07 2022 12:17 BST.
More ▼

Investors Chronicle View

The last IC recommendation on Mediclinic International PLC shares was Hold at 374.00 on 25 May 2022Read the full article
An LSEG Business
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
Markit Short Selling Activity © Markit. All rights reserved.
Although Markit has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.